| |
 |
CL Pharma Aktiengesellschaft Patents |
|
Assignee: CL Pharma Aktiengesellschaft
Address: Linz, AT
No. of patents: 10
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 5066810 |
3,5-dimethyl-4-methoxypyridine derivatives |
November 19, 1991 |
| A process for the preparation of compounds of formula I ##STR1## in which X is the radical OH or Cl, by the catalytic hydrogenation of 3,5-dimethyl-4-methoxy-2-cyanopyridine, subsequent reaction of the resulting 3,5-dimethyl-4-methoxy-2-aminomethylpyridine to give 3,5-dimethyl-4- |
| 5034391 |
Piperazinylalkyl-3(2H)-pyridazinones and the use thereof as agents lowering blood pressure |
July 23, 1991 |
| The invention relates to new piperazinylalkyl-3(2H)-pyridazinones of the formula ##STR1## in which the radicals R.sub.1 represents hydrogen, phenyl, benzyl, or (C.sub.1 -C.sub.6)-alkyl which is unsubstituted or substituted one or more times by hydroxyl, piperidine, morpholine or |
| 4965277 |
Allylaminoethylazoles |
October 23, 1990 |
| New allylaminoethylimidazoles of the formula: ##STR1## in which R is a hydrogen atom or an alkyl group containing 1 to 5 carbon atoms; each of Ar and Ar' is an unsubstituted phenyl group, a phenyl group substituted by one or more substituents selected from C.sub.1 -C.sub.3 alkyl, |
| 4927821 |
Enol ethers of 6-chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazine- 3-car |
May 22, 1990 |
| The invention relates to new enol ethers of 6-chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2- thiazine-3-carboxamide 1,1-dioxide of the formula ##STR1## in which R denotes (C.sub.1 -C.sub.6)-alkyl, (C.sub.5 -C.sub.7)-cycloalkyl or benzyl, and a process for their pre |
| 4925855 |
Imidazole derivatives and antimycotics containing them |
May 15, 1990 |
| New imidazole derivatives of the formula ##STR1## in which Ar denotes phenyl, biphenylyl, naphthyl or thienyl, each of which is optionally substituted by halogen, lower alkyl or lower alkoxy, R.sub.1 denotes hydrogen or lower alkyl, Alk denotes straight-chain or branched alkylene |
| 4877809 |
Novel 2-thienyloxyacetic acid derivatives, a process for their preparation and pharmaceutical pr |
October 31, 1989 |
| The invention relates to novel 2-thienyloxyacetic acid derivatives of the general formula ##STR1## in which R denotes a phenyl or thienyl group which is optionally mono- or polysubstituted by halogen, trifluoromethyl or C.sub.1 -C.sub.4 alkyl, and pharmaceutically usable salts th |
| 4841065 |
Isoxazole derivatives with antiviral activities and pharmaceutical products containing these |
June 20, 1989 |
| Substituted isoxazoles of the formula ##STR1## in which R.sub.1 denotes C.sub.1 -C.sub.4 alkyl, R.sub.2 denotes hydrogen, C.sub.1 -C.sub.4 alkyl chlorine or bromine, R.sub.3 and R.sub.4, which are the same or different are hydrogen or C.sub.1 -C.sub.4 alkyl, but not both hydrogen |
| 4814112 |
Single-stage process for preparing mixed-substituted 1,2-diacyl-sn-clycero-3-phosphocholines |
March 21, 1989 |
| Single-stage process for preparing mixed-substituted enantiomerically pure 1,2-diacyl-sn-glycero-3-phosphocholines of general formula I ##STR1## in which R.sub.1 and R.sub.2 are different and independently of each other denote a substituted or unsubstituted C.sub.1 to C.sub.24 -alkyl |
| 4812465 |
Triazole derivatives for use as antimycotic agents |
March 14, 1989 |
| Imidazole and triazole derivatives of the general formula ##STR1## in which Ar denotes thienyl or denotes phenyl, biphenylyl or naphthyl, each of which is substituted by halogen, lower alkyl or lower alkoxy, R.sub.1 denotes hydrogen or lower alkyl, Alk denotes straight-chain or b |
| 4795646 |
Process for the preparation of binder-free, tablettable granules of celiprolol hydrochloride |
January 3, 1989 |
| Process for the preparation of binder-free granules which can be compressed to give solid medicament forms, which consists in initially placing a predetermined amount of celiprolol hydrochloride, over 50% of which have a particle size below 40 .mu.m and not more than 10% have a particle |
|
|
|
